Analysis shows Omada members maintained weight, with minimal (0.8%) average weight change, one year after discontinuing GLP-1s for weight loss
Read Article
Omada Insights Lab shows virtual lifestyle programs may help maintain weight post-GLP-1 discontinuation, with 63.2% of participants maintaining or losing weight after a year.
Read Resource
She has multiple chronic conditions and was able to get support from her entire care team to make healthy changes. Here's her journey.
Watch Video
Omada for
Hypertension
Christina not only got support to make small changes to build healthy habits but with the support Christina got between visits, she was able to lower her medication dosage. Here’s her journey.
Watch Video
Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a public offering price of $19.00 pe
Read Article
Omada Health announces its initial public offering, offering 7.9 million shares at $18–$20 each, and plans to list on Nasdaq under the ticker symbol “OMDA.”
Read Article
On May 20, 2025, Omada Horizon Day showcased how our AI-powered innovations are transforming member relationships with food. Watch the recording of our Spring 2025 product innovation unveiling!
Watch Video
Introducing Omada Health's Nutritional Intelligence with AI-powered OmadaSpark! Experience real-time support to tackle emotional eating & make informed, lasting food choices for a healthier lifestyle
Read Article
This analysis found that lifestyle-focused virtual health program to support cardiometabolic disease management may lead to meaningful reductions in high-cost acute care encounters.
Read Article
Should you trust healthcare AI? Learn about safe development and deployment practices, and the future of AI regulation in healthcare.
Read Article
Omada Health presented three posters at the Society of Behavioral Medicine's Annual Meeting. New data demonstrates behavioral, mental, and physical health benefits of Omada's cardiometabolic programs.
Read Article
Omada’s Clinical Advisory Board demonstrates its commitment to rigorous clinical evaluation and helps underscore the impact of its behavior change programs
Read Article
This analysis showed that across diverse sociodemographic populations, Omada cardiometabolic members experienced improvements in depression and anxiety symptoms.
Read Article
Case Study: Learn how Omada Health and Sentara Health plans collaborate to advance health equity in government programs.
Read Resource
The collaboration between Stanford Health Care and Omada demonstrates the value of engaging with providers and health systems to realize the value of virtual care.
Read Resource
Omada Insights Lab surveyed and interviewed Omada members with a history of GLP-1 use to learn more about their unique needs and experiences.
Read Resource
Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.
Read Article
Cardiovascular disease (CVD) remains the leading cause of death among women, yet it is often misdiagnosed and/or undertreated. Join the discussion on the need for more focus on women's heart health.
Watch Video
New consumer data indicates that sustaining weight loss and overall well-being requires intervention beyond the GLP-1
Read Resource
Return on Health Framework for Realizing the Value of Virtual Care
Read Resource
Loading More...
